{"title": "Drug Alert: Voluntary Recall for Lamotrigine | Seizure Medication", "author": null, "url": "https://www.epilepsy.com/stories/drug-alert-taro-pharmaceuticals-issues-voluntary-nationwide-recall-lamotrigine-100-mg", "hostname": "epilepsy.com", "description": "On January 10, 2020, the U.S. Food and Drug Administration (FDA) published a company alert about a voluntary recall of lamotrigine 100 mg tablets from Taro Pharmaceuticals.", "sitename": "Epilepsy Foundation", "date": "2020-01-12", "cleaned_text": "Drug Alert: Taro Pharmaceuticals Issues Voluntary Nationwide Recall of Lamotrigine 100 mg tablets Epilepsy News From: Sunday, January 12, 2020 On January 10, 2020, the U.S. Food and Drug Administration (FDA) published a [company alert](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/taro-pharmaceuticals-usa-inc-issues-voluntary-nationwide-recall-lamotrigine-tablets-usp-100-mg-100) about a voluntary recall of [lamotrigine 100 mg](/tools-resources/seizure-medication-list/lamotrigine) tablets from Taro Pharmaceuticals. - Lamotrigine 100 mg tablets from lot # 331771 are being recalled due to possible contamination with another medicine. - People taking lamotrigine 100 mg tablets should call their pharmacy to check if their medicine is affected. - Lamotrigine from the affected lot can be taken back to the pharmacy and ask for a new supply. - Problems with any medication can be reported to the [FDA Medwatch Program](https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program). Important Please do NOT stop taking your seizure medicine suddenly. If you suspect you may have lamotrigine from the recalled lot, please call your pharmacy and get a new supply of lamotrigine. Editors note: Originally published January 12, 2020; republished February 21, 2020, to highlight important information Authored by Patty Obsorne Shafer RN, MN Reviewed by Barry Gidal PharmD Reviewed Date Sunday, January 12, 2020 "}